Merck Expands Biosafety Testing Laboratory in Singapore to Strengthen Services Across Asia Pacific
- Written by The Bulletin
- Expansion adds first BioReliance® Cell Line Characterization and GMP Next-GenerationSequencingin Asia Pacific
- Enhanced testing capabilities to deliver speed, sensitivity, and sustainability for biopharma customers in the region
- Supports industry shift to molecular methods and animal-free testing
SINGAPORE – Media OutReach Newswire – 11 August 2026 – Merck, a leading science and technology company, is expanding its Singapore lab to further strengthen analytical and biosafety testing services for customers across the Asia Pacific region.
